TrialBreast cancer research : BCR2006

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.

Elisabetta Munzone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.